Anaptysbio (ANAB) Non-Current Assets (2016 - 2026)
Anaptysbio (ANAB) reported Non-Current Assets of $13.58 million for Q1 2026, down 77.0% from $58.94 million a year earlier and down 4.0% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio posted Non-Current Assets of $14.15 million, down 72.8% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -6.7% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $51.96 million in FY2024 (+14.1%), $45.55 million in FY2023 (-72.1%), $163.18 million in FY2022 (+82.9%) and $89.19 million in FY2021 (+346.2%).
- The Q1 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2021.
- Year over year, Non-Current Assets has now declined in each of the last four quarters, with an average decline of 23.1% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 429.8%); the low point was Q1 2026 (a decline of 77.0%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $14.15 million (Q4 2025), $22.45 million (Q3 2025) and $43.34 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - | 13.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 14.15 Mn |
| Sep 30, 2025 | 22.45 Mn |
| Jun 30, 2025 | 43.34 Mn |
| Mar 31, 2025 | 58.94 Mn |
| Dec 31, 2024 | 51.96 Mn |
| Sep 30, 2024 | 44.74 Mn |
| Jun 30, 2024 | 60.03 Mn |
| Mar 31, 2024 | 33.42 Mn |
| Dec 31, 2023 | 45.55 Mn |
| Sep 30, 2023 | 59.33 Mn |
| Jun 30, 2023 | 78.57 Mn |
| Mar 31, 2023 | 114.64 Mn |
| Dec 31, 2022 | 163.18 Mn |
| Sep 30, 2022 | 168.06 Mn |
| Jun 30, 2022 | 151.04 Mn |
| Mar 31, 2022 | 112.76 Mn |
| Dec 31, 2021 | 89.19 Mn |
| Sep 30, 2021 | 37.69 Mn |
| Jun 30, 2021 | 28.51 Mn |
API Access
Anaptysbio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();